The Invoiceable Section Is Where Sites Leave Money on the Table
Most sites undercharge on research-paid items because no one reconciles the sponsor budget against the charge master. Here is...
Most sites undercharge on research-paid items because no one reconciles the sponsor budget against the charge master. Here is...
CRScube acquired Mednet in Nov 2025, uniting 84,000 site users under one AI-assisted EDC. Here's what that means for...
Decentralized supply management is breaking traditional cold-chain oversight. Here's what DSM failures cost sites in enrollment ramp and budget...
Moleculin closed Part A enrollment at 89 subjects in its pivotal AML MIRACLE trial. Here's what site directors and...
A mid-trial primary outcome amendment in a thrombectomy study reveals the operational chain reaction sites and sponsor clinops teams...
CHOICE-2 changed its primary endpoint after 283 enrollments with no interim data released. Here's what that timeline reveals about...
An intra-arterial alteplase trial changed its primary outcome at month 12 after 283 enrollments. Here's the clinops reality of...
A protocol-scoped MCA is a real deliverable, but it has hard limits. Here is what you can and cannot...
Radial's FDA-cleared Evoke EEG integration across 27 brain medicine clinics tests whether distributed neuroimaging endpoints can survive real-world site…
Mayo Test Drive completed at 97.5% across MCI, mild, and moderate dementia patients, here's what that means for Alzheimer's...